About
Venus Medtech International, based in Hangzhou, China, is a leading medical device company focused on transcatheter structural heart valve therapies. Founded in 2009, the company has established a strong presence in nearly 70 global markets, including Europe, Asia-Pacific, and Latin America. With around 691 employees, Venus Medtech is led by CEO Hou-Sen Lim and holds over 800 patents worldwide. The company offers a diverse range of products, including the VenusA-Valve series for aortic valve replacement, the VenusP-Valve for pulmonary valve treatment, and the Cardiovalve system for mitral regurgitation. Additionally, Venus Medtech develops other medical devices, such as a radiofrequency ablation system for hypertrophic cardiomyopathy and a renal artery denervation system for hypertension. The company is committed to innovation and actively conducts clinical trials to enhance its product offerings and expand treatment options for structural heart diseases.
Technologies
Keywords
Company Information
- Employees48
- Founded2009
- Annual Revenue$69306000
- Total Funding$498000000
Location
137 Kraijenhoffstraat, Amsterdam, North Holland, Netherlands, 1018 RG
